Abstract
RationaleTo assess the improvement in quality-of-life and depressive symptoms during long-term adjunctive therapy with eslicarbazepine acetate (ESL) in patients with refractory partial epilepsy.MethodsDuring an open-label extension of a phase 3...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Neurology, Neurosurgery & Psychiatry
Paper Title
Journal
Date
